Radiation Exposure in Spine Intervention Under Angiography

Evaluate radiation exposure and procedure times for continuous fluoroscopic monitoring during lumbar ESI

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Low Back Pain Back Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Joon-woo Lee

Seongnam-si, Gyeonggi-do, 463-707, South Korea

About this study

The purpose of this prospective study was to evaluate radiation exposure and procedure times for fluoroscopic monitoring during lumbar ESI with analyzing the differences among operators (experienced staff and trainee) and among different method for ESI.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Suspected of having radiculopathic low back pain

Exclusion criteria

Angiography is contraindicated

Treatment and study plan

Epidural steroid injection

Radiation

Epidural steroid injection

Primary outcomes

Radiation dose

Time frame: Treatment on the day

Radiation dose of patients with spine invervention under angiography

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

Phase 3 Study of Evaluate Radiation Exposure and Procedure Times for Continuous Fluoroscopic Monitoring During Lumbar ESI

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2012
First posted: Dec 18, 2012
Registry last updated: Dec 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed